Bio


Dr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.

Clinical Focus


  • Infectious Disease
  • Immunocompromised Host Infectious Disease

Academic Appointments


Professional Education


  • Fellowship: Stanford University Infectious Disease Fellowships (2016) CA
  • Fellowship: Stanford University Infectious Disease Fellowships (2015) CA
  • Medical Education: Rutgers Robert Wood Johnson Medical School (2009) NJ
  • Board Certification: American Board of Internal Medicine, Infectious Disease (2015)
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2012)
  • Residency: Rhode Island Hospital/Brown University (2012) RI

All Publications


  • Epidemiology of lower respiratory tract infections and community-acquired respiratory viruses in patients with bronchiolitis obliterans syndrome after hematopoietic cell transplant: a retrospective cohort study. Transplantation and cellular therapy Epstein, D. J., Liang, E. C., Sharifi, H., Lai, Y. K., Arai, S., Graber-Naidich, A., Sundaram, V., Nelson, J., Hsu, J. L. 2022

    Abstract

    Among 55 patients with bronchiolitis obliterans syndrome, 34 (61.8%) developed lower respiratory tract infections, which were associated with impaired lung function and a trend toward increased mortality. Rhinovirus/enterovirus and Pseudomonas aeruginosa infections predominated; 10 (18.2%) patients developed non-tuberculous mycobacterial infections.

    View details for DOI 10.1016/j.jtct.2022.07.016

    View details for PubMedID 35872303

  • Strongyloides Hyperinfection After Immunosuppression in an Immigrant From El Salvador A Case for Early Diagnosis and Treatment JCR-JOURNAL OF CLINICAL RHEUMATOLOGY Hoppenfeld, M., Kennedy, V., Sheth, K., Chang, A., Nelson, J., Fairchild, R. 2021; 27 (4): E128-+
  • Covid-19 in hospitalized lung and non-lung solid organ transplant recipients: a comparative analysis from a multicenter study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Heldman, M. R., Kates, O. S., Safa, K., Kotton, C. N., Georgia, S. J., Steinbrink, J. M., Alexander, B. D., Hemmersbach-Miller, M., Blumberg, E. A., Crespo, M. M., Multani, A., Lewis, A. V., Beaird, O. E., Haydel, B., La Hoz, R. M., Moni, L., Condor, Y., Flores, S., Munoz, C. G., Guitierrez, J., Diaz, E. I., Diaz, D., Vianna, R., Guerra, G., Loebe, M., Rakita, R. M., Malinis, M., Azar, M. M., Hemmige, V., McCort, M. E., Chaudhry, Z. S., Singh, P., Hughes, K., Velioglu, A., Yabu, J. M., Morillis, J. A., Mehta, S. A., Tanna, S. D., Ison, M. G., Tomic, R., Derenge, A. C., van Duin, D., Maximin, A., Gilbert, C., Goldman, J. D., Sehgal, S., Weisshaar, D., Girgis, R. E., Nelson, J., Lease, E. D., Fisher, C. E., Limaye, A. P., UW Covid-19 SOT Study Team, Lawrence, C. 2021

    Abstract

    Lung transplant recipients (LTR) with Covid-19 may have higher mortality than non-lung solid organ transplant recipients (SOTR), but direct comparisons are limited. Risk factors for mortality specifically in LTR have not been explored. We performed a multicenter cohort study of adult SOTR with Covid-19 to compare mortality by 28-days between hospitalized LTR and non-lung SOTR. Multivariable logistic regression models were used to assess comorbidity-adjusted mortality among LTR vs. non-lung SOTR and to determine risk factors for death in LTR. Of 1,616 SOTR with Covid-19, 1,051 (65%) were hospitalized including 117/159 (74%) LTR and 934/1457 (64%) non-lung SOTR (p=0.02). Mortality was higher among LTR compared to non-lung SOTR (24% vs. 16%, respectively, p=0.035) and lung transplant was independently associated with death after adjusting for age and comorbidities (aOR 1.7, 95% CI 1.0-2.6, p=0.05). Among LTR, independent risk factors for mortality included single lung transplant (aOR 2.8, 95% CI 1.0-7.7, p=0.04) and chronic lung allograft dysfunction (aOR 3.6, 95% CI 1.0-12.4, p=0.05), but not age >65 years, heart failure, or obesity. Among SOTR hospitalized for Covid-19, LTR had higher mortality than non-lung SOTR. In LTR, single lung transplant and chronic allograft dysfunction were independently associated with mortality.

    View details for DOI 10.1111/ajt.16692

    View details for PubMedID 34008917

  • Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease. American journal of obstetrics and gynecology Igbinosa, I., Miller, S., Bianco, K., Nelson, J., Kappagoda, S., Blackburn, B. G., Grant, P., Subramanian, A., Lyell, D., El-Sayed, Y., Aziz, N. 2020

    View details for DOI 10.1016/j.ajog.2020.08.001

    View details for PubMedID 32771381

  • Challenges in Diagnosis and Management of Nontuberculous Mycobacteria in Solid Organ Transplantation OBM Transplantation Nelson, J. K., Subramanian, A. 2019; 3 (1)
  • PROCALCITONIN IS NONSPECIFICALLY ELEVATED IN ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS Lau, E., Martin, B., Nelson, J. K. WILEY. 2019: S24
  • Strongyloides Hyperinfection After Immunosuppression in an Immigrant From El Salvador: A Case for Early Diagnosis and Treatment. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases Hoppenfeld, M. S., Kennedy, V., Sheth, K., Chang, A., Nelson, J., Fairchild, R. M. 2018

    View details for PubMedID 30074914

  • Donor-Derived Coccidioides immitis Endocarditis and Disseminated Infection in the Setting of Solid Organ Transplantation. Open forum infectious diseases Nelson, J. K., Giraldeau, G., Montoya, J. G., Deresinski, S., Ho, D. Y., Pham, M. 2016; 3 (3): ofw086-?

    Abstract

    Background.  Endocarditis is a rare manifestation of infection with Coccidioides. This is the first reported case of donor-derived Coccidioides endocarditis obtained from a heart transplant. Methods.  We present a unique case of donor-derived Coccidioides immitis endocarditis and disseminated infection in a heart transplant patient. We also conducted a review of the literature to identify other cases of donor-derived coccidioidomycosis in solid organ transplant recipients and reviewed their clinical characteristics. Results.  Fifteen prior cases of donor-derived coccidioidomycosis were identified. A majority of these cases were diagnosed by positive culture (83%). Mortality was high at 58%. Conclusions.  Clinicians should maintain a high index of suspicion for disseminated coccidioidomycosis in patients who received transplants with organs from donors with a history of residing in endemic regions.

    View details for DOI 10.1093/ofid/ofw086

    View details for PubMedID 27413765

  • Encephalitis caused by chikungunya virus in a traveler from the kingdom of tonga. Journal of clinical microbiology Nelson, J., Waggoner, J. J., Sahoo, M. K., Grant, P. M., Pinsky, B. A. 2014; 52 (9): 3459-3461

    Abstract

    Febrile travelers from countries with unique endemic pathogens pose a significant diagnostic challenge. In this report, we describe the case of a Tongan man presenting with fever, rash, and altered mental status. The diagnosis of Chikungunya encephalitis was made using a laboratory-developed real-time RT-PCR and serologic testing.

    View details for DOI 10.1128/JCM.01288-14

    View details for PubMedID 24958800